Genomes and Genes
female genital neoplasms
Summary: Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).
Publications221 found, 100 shown here
- [Pelvic exenterations for gynaecological cancer--a 10 year institutional review]Sueli Pinelo
Serviço de Ginecologia, Instituto Portugues de Oncologia, Porto
Acta Med Port 19:99-104. 2006..It is used for treatment of primary or recurrent tumours, or, more usually in treatment of recurrent cervical cancer...
- Mammaglobin expression in gynecologic malignancies and malignant effusions detected by nested reverse transcriptase-polymerase chain reactionKurt Grünewald
Department of Internal Medicine, University of Innsbruck, Innsbruck, Austria
Lab Invest 82:1147-53. 2002....
- Positron emission tomography in gynecologic cancerTzu Chen Yen
Department of Nuclear Medicine, Molecular Imaging Center, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan
Semin Nucl Med 36:93-104. 2006..Evaluating PET by clinical benefit is specific to the individual tumor and an attractive new endpoint...
- PET imaging in gynecologic malignanciesRakesh Kumar
Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, 110 Donner Building, Philadelphia, PA 19104, USA
Radiol Clin North Am 42:1155-67, ix. 2004..Normal FDG activity in the gastrointestinal tract and bladder may obscure some lesions. Combined PET/CT can help in localizing lesions and differentiating between pathologic and physiologic uptake in the pelvis and abdomen...
- Quality of life: gynaecological cancersS Pignata
Oncologia Medica B Istituto Nazionale Tumori, Naples, Italy
Ann Oncol 12:S37-42. 2001..In this report, we will discuss the aspects affecting the QoL in gynaecological cancer in relation to surgical treatment, medical therapy, and follow-up...
- Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusion-weighted magnetic resonance imagingGo Nakai
Department of Radiology, Osaka Medical College, Osaka, Japan
J Comput Assist Tomogr 32:764-8. 2008..In this study, the potential in detecting and evaluating pelvic lymph node metastases on body diffusion-weighted (DW) images was evaluated in patients with gynecologic malignancies...
- Health-related quality of life in gynecological oncology: instruments and psychometric propertiesW Boling
Department of Health and Human Performance, University of Houston, University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4095, USA
Int J Gynecol Cancer 13:5-14. 2003....
- USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: preliminary resultsThomas M Keller
Institute of Diagnostic Radiology, Zurich University Hospital, Zurich, Switzerland
Eur Radiol 14:937-44. 2004..However, the low sensitivity in the present study is a limitation for the clinical application of this technique...
- The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignanciesDan Grisaru
Department of Obstetrics and Gynecology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Gynecol Oncol 94:680-4. 2004..To evaluate the diagnostic accuracy of integrated positron emission tomography/computerized tomography (PET/CT) in patients with gynecological cancer...
- Pearls and pitfalls of MR lymphography in gynecologic malignancyPriya Narayanan
Academic Department of Radiology, St Bartholomew s Hospital, Dominion House, 59 Bartholomew Close, London EC1A 7ED, England
Radiographics 29:1057-69; discussion 1069-71. 2009..However, as with any technique, there are pitfalls that the radiologist must be aware of to avoid interpretative errors...
- Prospective assessment of quality of life of female cancer patientsE Greimel
Department of Obstetrics and Gynecology, Karl Franzens University Graz, Graz, 8036, Austria
Gynecol Oncol 85:140-7. 2002....
- Quality of life in patients attending a low-risk gynaecological oncology follow-up clinicR L Leake
King Edward Memorial Hospital, Bagot Road, Subiaco, Western Australia, Australia
Psychooncology 10:428-35. 2001..Patients living with partners experienced deterioration in sexual functioning. CONCLUSIONS: Patients attending the low risk follow-up clinic after gynaecological malignancy have a good overall QOL...
- Quality of life and mood in women receiving extensive chemotherapy for gynecologic cancerS K Lutgendorf
University of Iowa, Department of Psychology, Iowa City, Iowa 52242, USA
Cancer 89:1402-11. 2000..Quality of life (QOL) and mood were investigated among women who had received intensive chemotherapy for at least 1 year for advanced gynecologic cancers. Relationships of coping styles to QOL and mood in these patients also were examined...
- Quality of life after treatment for gynecologic malignancies: a pilot study in an outpatient clinicBrigitte E Miller
Department of Obstetrics and Gynecology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
Gynecol Oncol 87:178-84. 2002..The objective of this study was to determine the health-related quality of life (QOL) of disease-free patients after therapy for gynecologic malignancies at follow-up in an outpatient clinic...
- Sentinel lymph node mapping in gynecologic malignanciesP V Loar
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 48109 0276, USA
Int J Gynaecol Obstet 99:69-74. 2007..Sentinel node mapping is currently being investigated for treatment of gynecologic cancers. Recent studies show promise for incorporating the sentinel node mapping technique for treatment of several gynecologic malignancies...
- Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patientsBrenda Laky
Queensland Centre for Gynaecological Cancer, The Royal Brisbane and Women s Hospital, Brisbane, Australia
Am J Clin Nutr 87:1678-85. 2008..Few studies have assessed global nutritional assessment tools and body-composition measurements in gynecologic cancer patients...
- Evaluation of quality of life in Chinese patients with gynaecological cancer: assessments by patients and nursesHong Zhao
School of Nursing, Peking Union Medical College, Beijing, China
Int J Nurs Pract 9:40-8. 2003..The nurses need to be trained to become more sensitive and competent in assessing patients' subjective information...
- Complementary and alternative medicine use in patients with gynecological cancers in EuropeA Molassiotis
School of Nursing, University of Manchester, United Kingdom
Int J Gynecol Cancer 16:219-24. 2006..It is important to discuss CAM use with gynecological cancer patients, as they frequently use it and such use may have implications for clinical practice...
- Malnutrition among gynaecological cancer patientsB Laky
Queensland Centre for Gynaecological Cancer, The Royal Brisbane and Women s Hospital, Brisbane, Australia
Eur J Clin Nutr 61:642-6. 2007..To assess the nutritional status of patients with gynaecological cancer...
- Quality of life and mood in women with gynecologic cancer: a one year prospective studySusan K Lutgendorf
Department of Psychology, University of Iowa, Iowa City, IA 52242, USA
Cancer 94:131-40. 2002..Quality of life (QOL) and mood were prospectively investigated during the first year of treatment among women with gynecologic cancers. Relationships of coping styles to QOL and mood were examined...
- Prognostic and therapeutic importance of lymphadenectomy in gynecological cancersA Ayhan
Department of Obstetrics and Gynaecology, Division of Gynaecological Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
Eur J Gynaecol Oncol 25:279-86. 2004..This study discusses the prognostic and therapeutic importance of lymphadenectomy in ovarian, endometrial, cervical and vulvar cancers...
- Quality of life considerations in gynecologic cancer. FIGO 26th Annual Report on the Results of Treatment in Gynecological CancerRichard T Penson
Harvard Medical School, Boston, MA, USA
Int J Gynaecol Obstet 95:S247-57. 2006..The QOL issues facing gynecologic cancer patients, the use of validated QOL instruments, recent advances in the evaluation of interventions, and changes in concepts related to QOL are reviewed...
- A longitudinal study on quality of life after gynecologic cancer treatmentY M Chan
Department of Obstetrics and Gynecology, University of Hong Kong, Hong Kong SAR, People s Republic of China
Gynecol Oncol 83:10-9. 2001..The objective was to describe the pattern of quality of life (QOL) over time and to assess the impact of age, symptoms, disease parameters, and treatment on the overall QOL...
- Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomographyA D Williams
Department of Imaging, Hammersmith Hospital, Imperial College School of Medicine, Du Cane Rd, London W12 0HS, United Kingdom
AJR Am J Roentgenol 177:343-8. 2001..The poor results of PET in the pelvis are attributed to urinary (18)F-FDG in the ureters or bladder, which may mask or imitate lymph node metastases...
- Magnetic resonance lymphography: a novel technique for lymph node assessment in gynecologic malignanciesP Narayanan
Department of Radiology, St Bartholomews Hospital, London, UK
Cancer Biomark 5:81-8. 2009..Magnetic resonance lymphography (MRL) using iron oxide nanoparticles is a new technique for lymph node assessment which has shown much promise. This article discusses the applications of MRL in the setting of gynecological malignancy...
- Tissue characterization in the female pelvis by means of MR imagingE S Siegelman
Department of Radiology, University of Pennsylvania Medical Center, Philadelphia 19104 4283, USA
Radiology 212:5-18. 1999..Consideration of the tissue composition of various pathologic processes in the pelvis can result in more systematic approaches to image interpretation and thus narrow the differential diagnosis...
- Predictors of complications and hospital stay in gynecologic cancer surgeryM M Dean
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, Louisiana 70121, USA
Obstet Gynecol 97:721-4. 2001..This information can be used to coordinate preoperative and postoperative hospital care and be a reference for certain future disease management systems...
- Prognostic nutritional index in relation to hospital stay in women with gynecologic cancerJ T Santoso
Division of Gynecologic Oncology, University of Texas Medical Branch at Galveston, Galveston, USA
Obstet Gynecol 95:844-6. 2000..To estimate the prevalence of malnutrition, correlate it with length of hospital stay, and evaluate laboratory tools to define it in gynecologic oncology...
- Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sitesJ J Carter
Program in Cancer Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA
Cancer Res 61:1934-40. 2001....
- Gynecologic cancer patients' psychosocial needs and their views on the physician's role in meeting those needsB E Miller
Section on Gynecologic Oncology, Department of Obstetrics and Gynecology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
Int J Gynecol Cancer 13:111-9. 2003..Most patients surveyed want physicians to take an active role in dealing with psychosocial needs...
- Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignanciesP A Fasching
Department of Gynecology and Obstetrics, University of Erlangen, Universitaetsstrasse 21 23, 91054, Erlangen, Germany
Support Care Cancer 15:1277-84. 2007..Our interest was to evaluate the association between CAM use and the patients' quality of life/life satisfaction (QoL/LS)...
- The virtues and pitfalls of minimally invasive surgery for gynecological malignancies: an updateJ M Childers
Arizona Oncology Associates, Tucson 8512, USA
Curr Opin Obstet Gynecol 11:51-9. 1999..The reader is updated by a review of the reports published over the past year and a half...
- Analysis of failed and complicated laparoscopy on a gynecologic oncology serviceG H Eltabbakh
Gynecologic Oncology, University of Vermont, Burlington, Vermont 05401, USA
Gynecol Oncol 74:477-82. 1999..To assess the incidence of and factors that predict failed or complicated operative laparoscopy on a gynecologic oncology service...
- Psychosocial adjustment in gynecologic cancer survivors: a longitudinal study on risk factors for maladjustmentY M Chan
Department of Obstetrics and Gynaecology, Queen Mary Hospital, Hong Kong SAR, China
Gynecol Oncol 80:387-94. 2001..038). CONCLUSION: Most patients adapted well. Patients at risk for psychosocial maladjustment include those who are treated surgically, less educated, and without religious belief...
- The impact of anemia and its treatment on patients with gynecologic malignanciesSusana Campos
Department of Medical Oncology, Dana Farber Cancer Center, Boston, MA 02115, USA
Semin Oncol 29:7-12. 2002..Therefore, epoetin alfa treatment should be considered in this patient population...
- Major complications following exenteration in cases of pelvic malignancy: a 10-year experienceDariusz Wydra
Department of Gynecology of Medical University of Gdansk, 80 402 Gdansk ul Kliniczna 1 A, Poland
World J Gastroenterol 12:1115-9. 2006..To analyze the major complications after exenteration of gynecological and rectal malignancies...
- Advancing women's cancer care. Report from the 37th Annual Meeting of the Society of Gynecologic Oncologists, Palm Springs, Calif., USA, March 22-26, 2006Joanie Mayer Hope
Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY, USA
Gynakol Geburtshilfliche Rundsch 46:214-7. 2006
- [Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region]Wei Huang
Department of Gynecologic Oncology, Affiliated Cancer Hospital of Medical University of Guangxi, Nanning, China
Zhonghua Fu Chan Ke Za Zhi 42:22-5. 2007..To investigate the constitutive characteristics and the change trend of gynecologic malignant tumors in hospitalized patients in Guangxi Zhuang Autonomous Region over the recent 20 years...
- Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignanciesMohit Kasibhatla
Department of Radiation Oncology, Dartmouth Hitchcock Medical Center, Hanover, NH 03756, USA
Int J Radiat Oncol Biol Phys 65:398-403. 2006..0...
- Neoadjuvant chemotherapy in gynecological cancersA Ayhan
Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Hacettepe, Ankara, Turkey
Eur J Gynaecol Oncol 27:11-5. 2006..The number of studies concerning endometrial, vulvar and vaginal cancers are few in the area of neoadjuvant chemotherapy...
- Gynaecological malignancies in pregnancy: a reviewMartin K Oehler
Department of Gynaecological Oncology, Westmead Hospital, University of Sydney, Westmead, New South Wales, Australia
Aust N Z J Obstet Gynaecol 43:414-20. 2003..In the present review, recent diagnostic and treatment strategies for cervical, ovarian, vulvar and endometrial carcinomas during pregnancy are presented...
- Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignanciesMenelaos Zafrakas
Institute of Pathology, University Hospital Aachen, RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany
BMC Cancer 6:88. 2006....
- [Malignant tumors of the female genital track in the elderly]Leszek Gottwald
I Kliniki Ginekologii i Onkologii Ginekologicznej Instytutu Ginekologii i Połoznictwa Uniwersytetu Medycznego w łodzi
Ginekol Pol 74:714-7. 2003..The coexisting another diseases often limits the possibility of the operative treatment in those cases...
- Laparoscopy and oncology: where do we stand today?Theodoros D Theodoridis
First Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Hippokration Hospital, 8 Agias Theodoras Street, 546 42 Thessalonoki, Greece
Ann N Y Acad Sci 997:282-91. 2003..Until results from these trials are available, laparoscopic oncologic procedures should be performed only in an investigational setting by expert teams...
- Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological dataHui Juan Yang
Department of Gynecologic Oncology, Fudan University Cancer Hospital, Shanghai, China
BMC Cancer 6:212. 2006..The abnormal promoter methylation might be a potential molecular marker for cancer management...
- Laparoscopic paraaortic left-sided transperitoneal infrarenal lymphadenectomy in patients with gynecologic malignancies: technique and resultsChristhardt Köhler
Department of Obstetrics and Gynecology, Friedrich Schiller University, Bachstrasse 18, 07740, Jena, Germany
Gynecol Oncol 91:139-48. 2003..We evaluated whether left-sided paraaortic inframesenteric lymphadenectomy can be extended up to the left renal vein by laparoscopy...
- Fertility preservation options for women with malignanciesEnbal Marhhom
Department of Obstetrics and Gynecology, Sapir Medical Center, Kfar Saba, Sackler Faculty of Medicine, Tel Aviv University, Israel
Obstet Gynecol Surv 62:58-72. 2007....
- Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancersM C Fleisch
Universitaets Frauenklinik, Heinrich Heine Universitaet, Duesseldorf, Germany
J Surg Oncol 95:476-84. 2007..We wanted to identify factors which allow predicting long-term survival after pelvic exenteration (PE) for locally advanced or recurrent gynecologic malignancies...
- Malignant tumours of female genital tract in North Eastern NigeriaO Kyari
Department of Obstetric and Gynaecology, Maiduguri Teaching Hospital, P M B 1414, Maiduguri, Nigeria
East Afr Med J 81:142-5. 2004..To ascertain the pattern and frequency of malignant tumours of female genital tract in North Eastern Nigeria...
- Hormonal replacement therapy after gynaecological cancerNicoletta Biglia
Institute for Cancer Research and Treatment IRCC, Academic Department of Gynaecological Oncology, University of Turin, Candiolo, Italy
Gynakol Geburtshilfliche Rundsch 46:191-6. 2006..The use of HRT in breast cancer patients is, at present, considered contra-indicated, even if results of clinical trials are not concordant. Therapeutic non-hormonal alternatives may be proposed to these patients...
- Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancersMaria L N Dias
Department of Gynecology, Medical School Hospital, University of Sao Paulo, Sao Paulo, Brazil
Cancer Chemother Pharmacol 59:105-11. 2007..Here, the pharmacokinetics of LDE-paclitaxel oleate and the ability of LDE to concentrate the drug in the tumor were investigated in patients with gynecologic cancers...
- [Hereditary predispositions to gynaecological cancers]I Coupier
Service de Genetique Medicale, Inserm 540, CHU de Arnaud de Villeneuve, 371, avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex, France
Gynecol Obstet Fertil 33:851-6. 2005..An individual and family medical management ranging from simple monitoring to prophylactic surgery is proposed to these predisposed people...
- Ureteral surgery performed by a university gynecologic oncology serviceMitchel S Hoffman
University of South Florida, Division of Gynecologic Oncology, Tampa, FL, USA
Am J Obstet Gynecol 195:562-6; discussion 566-7. 2006....
- Audit of preoperative and early complications of laparoscopic lymph node dissection in 1000 gynecologic cancer patientsDenis Querleu
Institut Claudius Regaud Cancer Center, Toulouse, France
Am J Obstet Gynecol 195:1287-92. 2006..Establish the reliability and safety of minimal invasive surgery in gynecologic oncology in a large-scale study. Estimate the complication rate on a large sample size...
- Radical gynecologic surgery for cancerSarah H Hughes
Division of Gynecologic Oncology, Caritas St Elizabeth s Medical Center of Boston, 736 Cambridge Street, Boston, MA 02135 2997, USA
Surg Oncol Clin N Am 14:607-31, viii. 2005
- Perioperative morbidity and mortality of gynecological oncologic surgery in elderly womenI Ben-Ami
Department of Obstetrics and Gynecology, Assaf Harofeh Medical Center, Zerifin 70300, Israel
Int J Gynecol Cancer 16:452-7. 2006..Chronological age by itself should not be a contraindication for the treatment of elderly women with gynecological malignancy since it is a poor predicting factor for perioperative morbidity...
- Radiation therapy for gynecologic malignanciesKristin A Bradley
Department of Human Oncology, University of Wisconsin Medical School, University Hospital and Clinics, K4 B100 Radiotherapy, 600 Highland Avenue, Madison, WI 53792, USA
Hematol Oncol Clin North Am 20:347-61. 2006....
- Surgical staging of gynecologic malignancies: the role of laparoscopy and sentinel node technologyRobert Kim
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cleveland Clinic Foundation, OH 44195, USA
Surg Oncol Clin N Am 14:267-88. 2005
- New treatment concepts for gynecologic pelvic malignancies: neoadjuvant therapiesAntonella Restivo
Brown University, Providence, RI 02905, USA
Surg Oncol Clin N Am 14:239-47. 2005
- Treatments for gynaecological cancersSean Kehoe
Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK
Best Pract Res Clin Obstet Gynaecol 20:985-1000. 2006..This review will endeavour to focus on the evidence base, though inevitably, non-evidence based practice is unavoidable...
- p16 expression in the female genital tract and its value in diagnosisCiaran J O'Neill
Department of Pathology, Royal Group of Hospitals Trust, Grosvenor Road, Belfast BT12 6BL, Northern Ireland
Adv Anat Pathol 13:8-15. 2006..Some ovarian serous carcinomas, similar to their uterine counterparts, are p16-positive...
- Gonadotropin-releasing hormone (GnRH) agonist triptorelin inhibits estradiol-induced serum response element (SRE) activation and c-fos expression in human endometrial, ovarian and breast cancer cellsCarsten Gründker
Department of Gynecology and Obstetrics, Georg August University, D 37099 Göttingen, Germany
Eur J Endocrinol 151:619-28. 2004..In this study, we demonstrate that the GnRH agonist triptorelin inhibits estradiol (E2)-induced cancer cell proliferation...
- [Endoscopic surgery for gynecologic malignancy--less invasive, more radical]Masaaki Andou
Dept of Obstetrics and Gynecology, Takarazuka City Hospital
Gan To Kagaku Ryoho 31:1494-500. 2004..As for the long-term results, although the number of cases and the observation period are limited, at present the outcome does not differ greatly from the results of conventional laparotomy...
- Microsatellite instability in mitochondrial genome of common female cancersY Wang
Department of Obstetrics and Gynecology, Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong SAR, China
Int J Gynecol Cancer 16:259-66. 2006..Furthermore, carriers of a germ-line T to C polymorphism at np 16189 could be more susceptible to breast cancer development in light of the higher frequency detected in cancer patients than in normal individuals...
- Comparison of mohs micrographic surgery and wide excision for extramammary Paget's diseaseWilliam J O'Connor
Department of Dermatology, Mayo Clinic, Scottsdale, Arizona Mayo Clinic, Rochester, Minnesota, USA
Dermatol Surg 29:723-7. 2003..Extramammary Paget's disease is a rare cutaneous adenocarcinoma that occurs in an apocrine gland distribution mainly in the anogenital region...
- Genetic abnormalities of cell proliferation, invasion and metastasis, with special reference to gynaecological cancersGajanan V Sherbet
School of Electrical, Electronic and Computer Engineering, Merz Court, University of Newcastle upon Tyne, Newcastle upon Tyne NE1 7RU, U K
Anticancer Res 23:1357-71. 2003..The clinical effectiveness and reliability of these genes as markers of cancer progression and predictors of disease prognosis have been evaluated...
- Radiation therapy for gynecologic cancerKrishnansu Sujata Tewari
Division of Gynecologic Oncology, The University of California, Irvine 92868, USA
J Obstet Gynaecol Res 28:123-40. 2002
- Risk of colorectal cancer in women with a prior diagnosis of gynecologic malignancyRadhika Srinivasan
Department of Medicine, Division of Gastroenterology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
J Clin Gastroenterol 41:291-6. 2007..Earlier studies regarding the risk of colorectal cancer (CRC) in women with a prior diagnosis of gynecologic malignancies have revealed conflicting results. We sought to further clarify this association...
- Gynecologic malignancies in older womenR Mirhashemi
Jackson Memorial Hospital, University of Miami, Familial Ovarian/Breast Cancer Center, Miami, Florida, USA
Oncology (Williston Park) 15:580-6; discussion 592-4, 597-8. 2001..The main considerations in the treatment of ovarian, endometrial, cervical, and vulvar cancer are discussed...
- Pathological findings of gynecologic organs obtained at female radical cystectomySam S Chang
Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA
J Urol 168:147-9. 2002..We evaluated the pathological features of reproductive organs removed during exenteration to determine the incidence of malignant pathology in these organs and the need for removal...
- Clinical trials in gynecological cancerE L Trimble
National Cancer Institute Cancer Therapy Evaluation Program, Bethesda, MD, USA
Int J Gynecol Cancer 17:547-56. 2007..Other critical issues include support from government and charities and government regulations...
- Neuroendocrine tumors of the genital tractJ H Eichhorn
James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Boston 02114, USA
Am J Clin Pathol 115:S94-112. 2001..It is important to distinguish prostatic small cell carcinoma from poorly differentiated adenocarcinoma with small cells. Small cell neuroendocrine carcinomas also occur rarely in the scrotum, penis, and penile urethra...
- [Early diagnosis of gynaecologic and breast cancers]W Grzybowski
Ginekol Pol 72:1465-72. 2001..The majority of Polish women suffer from breast, cervix, ovary and endometrial cancer. This paper shows common and new methods in early diagnosis of neoplasmic diseases...
- Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated seriesAileen Caceres
Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Gynecol Oncol 108:482-5. 2008..Our objective was to review and update our experience with colonic stent placement for patients presenting with a large-bowel obstruction due to recurrent gynecologic malignancy...
- Diet and environmental carcinogenesis in breast/gynaecological cancersCristina Bosetti
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
Curr Opin Obstet Gynecol 14:13-8. 2002..Alcohol appears to be related to the risk of breast cancer and overweight is associated with post-menopausal breast cancer and is strongly related to the risk of endometrial cancer...
- Continent ileocolonic urinary diversion (Rome pouch) for gynecologic malignancies: technique and feasibilityPierluigi Benedetti Panici
Department of Obstetrics and Gynecology, La Sapienza University of Rome, Viale del Policlinico 155, 00161 Rome, Italy
Gynecol Oncol 107:194-9. 2007..To describe the technique, feasibility and early complications of "Rome pouch" urinary diversion...
- Hemostatic effects of high-dose megestrol acetate therapy in patients with advanced gynecological cancerC Oberhoff
University Hospital Essen, Center of Gynecology and Obstetrics, Department of Gynecological Oncology, Hufelandstr. 55, D-45122 Essen, Germany
Gynecol Endocrinol 15:341-8. 2001..The observed incidence of thrombosis might be the consequence of other risk factors such as tumor-induced hypercoagulability, simultaneous chemotherapy or other individual thrombosis risk factors...
- Heat shock protein expression and immunity: relevance to gynecologic oncologyS S Witkin
Department of Obstetrics and Gynecology, Weill Medical College of Cornell University New York, New York 10021, USA
Eur J Gynaecol Oncol 22:249-56. 2001..The possible exploitation of the properties of heat shock proteins for development of unique anti-cancer therapies in individuals resistant to traditional treatment is currently under active investigation...
- Radiographic imaging in gynecologic oncologyJ T Soper
Division of Gynecologic Oncology, Box 3079, Duke University Medical Center, Durham, NC 27710, USA
Clin Obstet Gynecol 44:485-94. 2001..Further refinements of currently available techniques or newer techniques, however, are needed to increase the sensitivity for detection of subclinical or microscopic metastases in patients with gynecologic malignancies...
- Urologic function and urodynamic evaluation of urinary diversion (Rome pouch) over time in gynecologic cancers patientsRoberto Angioli
Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy
Gynecol Oncol 107:200-4. 2007....
- Gynecologic cancers: factors affecting survival after pulmonary metastasectomyJose M Clavero
Division of General Thoracic Surgery, Rochester, Minnesota, USA
Ann Thorac Surg 81:2004-7. 2006..Little information is available regarding long-term survival after pulmonary metastasectomy for gynecologic malignancies...
- Explorative laparoscopy prior to exenterative surgeryChristhardt Köhler
Department of Gynecology, Friedrich Schiller University, Bachstrasse 18, 07740 Jena, Germany
Gynecol Oncol 86:311-5. 2002..The objective of this study was to identify the advantages and limits of laparoscopy for assessment of eligibility for exenterative procedures in patients with gynecologic malignancies...
- Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositionsJohnathan M Lancaster
H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
Gynecol Oncol 107:159-62. 2007..This commentary provides guidance on identification of patients who may benefit from hereditary cancer risk assessment for Hereditary Breast/Ovarian Cancer and the Lynch/Hereditary Non-Polyposis Colorectal Cancer syndrome...
- [Paclitaxel and carboplatin with or without pirarubicin (THP-ADR) as first line chemotherapy in elderly patients]Shoji Nagao
Dept of Obstetrics and Gynecology, Okayama University Medical School
Gan To Kagaku Ryoho 30:243-9. 2003..The overall response rates were equivalent among elderly and younger patients (69% and 78%), respectively. The regimen consisting of paclitaxel and carboplatin without THP-ADR was applied safely to elderly patients...
- The prevalence of tumors of the breast and female genital tract in ItalyM Sant
Epidemiology Division, National Cancer Institute (INT, Milan, Italy
Tumori 85:382-6. 1999..The prevalence of corpus uteri cancer decreased slightly in the elderly only, whereas that of cervix uteri cancer decreased at all ages...
- Colorectal function preservation in posterior and total supralevator exenteration for gynecologic malignancies: an 89-patient seriesV Moutardier
Institut J Paoli l Calmettes and Université de la Méditerranée, 232 Bd de Sainte Marguerite, 13009 Marseille, France
Gynecol Oncol 89:155-9. 2003..The objective of this study was to analyze our experience with colorectal function preservation at the time of pelvic exenteration...
- [Endoscopic management of gynecological malignancies: an update. 2007]Michel Canis
Gynécologie Obstétrique et Médecine de la Reproduction, université d Auvergne Clermont 1, Polyclinique de l Hotel Dieu, CHU de Clermont Ferrand
Bull Acad Natl Med 191:1357-65; discussion 1365-6. 2007..An excellent knowledge of the principles of endoscopy and of oncologic surgery is required. Training in endoscopic oncological techniques will be a major challenge in the field of gynecologic surgery in coming years...
- Mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) chemotherapy for gynecological sarcomasM L Pearl
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Medicine, State University of New York at Stony Brook, Stony Brook, New York, USA
Int J Gynecol Cancer 12:745-8. 2002..It remains to be established if any combination chemotherapy regimen is better than single agent treatment...
- Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancerJens Ricke
Department of Radiology, Charite Virchow Klinikum, Medical Faculty, Humboldt University, Augustenburgerplatz 1, 13353 Berlin, Germany
Eur Radiol 13:943-9. 2003..Magnetic resonance imaging based on contrast-enhanced fat-saturated T1 SE sequences improves planning of cytoreduction preceding chemotherapy in advanced primary or relapsed ovarian carcinoma...
- Small cell carcinoma of the female genital tractSara Crowder
Mid Missouri Gynecologic Oncology, Columbia, MO 65201, USA
Semin Oncol 34:57-63. 2007..Indeed, the majority of patients have an early demise with extensive distant disease. We review the clinical features, evaluation, and management of SCC of the female genital tract based on a comprehensive review of the literature...
- Inherited risk of women's cancers: what's changed for the practicing physician?Thomas S Frank
Myriad Genetic Laboratories, Salt Lake City, Utah, USA
Clin Obstet Gynecol 45:671-83; discussion 730-2. 2002
- [Gynecological cancers and pregnancy: the point of view of the oncology gynecologist]Philippe Morice
Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif
Bull Cancer 89:765-71. 2002..But such management needs to be determined in a multidisciplinary staff with oncologists, neonatologists, obstetricians but also the point of view of the patient...
- Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?Suzuko Moritani
Department of Pathology and Clinical Laboratories, Nagoya Medical Center, Nagoya, Aichi 460 0001, Japan
Hum Pathol 39:666-71. 2008..However, the availability of GCDFP-15 is limited because of the low positive rate of GCDFP-15 in invasive micropapillary carcinomas...
- Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivityPeter G Rose
Case Western Reserve University, Ireland Cancer Center, Cleveland, OH 44106, USA
Gynecol Oncol 89:429-33. 2003....
- Occupational female breast and reproductive cancer mortality in British Columbia, Canada, 1950-94Amy C MacArthur
Cancer Control Research Program, BC Cancer Agency, Vancouver, BC V5Z 1L3, Canada
Occup Med (Lond) 57:246-53. 2007..It has been postulated that recent increases in female breast and reproductive cancers may be, in part, attributable to occupational exposures...
- Trace elements analysis of ascitic fluid in benign and malignant diseasesHandan Ak Celik
Department of Biochemistry, Ege University School of Medicine, Bornova 35100 Izmir, Turkey
Clin Biochem 35:477-81. 2002..To evaluate differences in ascitic fluid trace element concentrations which might be useful in discrimination between benign and malignant ascites...
- Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissuesA W Brandenberger
Reproductive Endocrinology Center, University of California, San Francisco, 94143 0556, USA
J Clin Endocrinol Metab 83:1025-8. 1998..HEY did not contain detectable amounts of either ER after 40 cycles of RT-PCR. We found no evidence of differential splicing or major deletions in almost the entire coding region of ER-beta in either normal ovaries or tumor samples...
- Papillary serous carcinoma of the peritoneum coexisting with or after endometrial carcinomaMarco M Altaras
Gynecologic Oncology Unit of the Department of Obstetrics and Gynecology, Meir Hospital, Kfar Saba 44281, Israel
Gynecol Oncol 84:245-51. 2002..The aim of this investigation was to describe our experience in treating five patients diagnosed with PSCP synchronously with EC and two others who developed PSCP metachronously after EC...
- Sexual dysfunction in patients with gynecologic neoplasms: a retrospective pilot studyAlison Amsterdam
Department of Surgery, Division of Gynecology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Sex Med 3:646-9. 2006..Little is known regarding the impact of a sexual health program on the sexual functioning of patients with a history of a gynecologic malignancy...
- Practice patterns of radiotherapy in endometrial cancer among member groups of the gynecologic cancer intergroupWilliam Small
RTOG, Philadelphia, PA, USA
Int J Gynecol Cancer 19:395-9. 2009..To describe radiotherapeutic practice of the treatment of endometrial cancer in members of the Gynecologic Cancer Intergroup (GCIG)...
- Fine-needle aspiration cytology of malignant fibrothecoma of the ovaryG C Yang
Department of Pathology, New York University Medical Center, New York, New York 10016, USA
Diagn Cytopathol 21:284-6. 1999..Cytodiagnosis of nonepithelial ovarian neoplasms can be difficult. However, it is not impossible, especially for recurrent tumors with previously established histodiagnosis. Diagn. Cytopath. 21:284-286, 1999...
- HER-2 NEU PROTO-ONCOGENE IN OVARIAN & ENDOMETRIAL CANCERMichael Press; Fiscal Year: 1993..the HER-2/neu proto-oncogene is clinically important in human gynecologic neoplasms and to understand the mechanisms by which this cellular oncogene regulates the metabolism of normal and malignant cells of the female reproductive tract..
- GYNECOLOGIC ONCOLOGY GROUPJames Thigpen; Fiscal Year: 1980..Current input is significant in all 4 of these areas as is documented in this application. ..
- CYCLIC GMP LEVELS IN GYNECOLOGIC NEOPLASMSChandralekha Duttagupta; Fiscal Year: 1980....
- Facilitating Informed Decisions for MSI TestingSharon Manne; Fiscal Year: 2008..The CD-ROM intervention will be developed with a view towards future dissemination. ..
- Tailored Intervention for Melanoma Patients' FamiliesSharon Manne; Fiscal Year: 2008..396 family members will complete the study. Outcomes will be evaluated in terms of TCE, SSE and sun protection habits, as well as changes in attitudes and knowledge about CMM [unreadable] [unreadable]..
- Colon Cancer Screening for Cancer Patients' FamiliesSharon Manne; Fiscal Year: 2006..After receiving the intervention information, participants will be interviewed again six months later regarding CRC screening behaviors and attitudes to assess the impact of the intervention. ..
- Improving Patient Adherence to Cancer TreatmentKathleen Ell; Fiscal Year: 2004..5 IMPAACT intervention effects will be mediated by changes in targets of the components of the intervention, viz., strengthened intentions, reduced emotional barriers particularly depression, and reduced practical and system barriers. ..
- Multifaceted Depression Diabetes Program for HispanicsKathleen Ell; Fiscal Year: 2008..e., diet, exercise, checking blood glucose, and taking diabetic medication), decreased HbA1c levels and diabetes symptoms; and c) will improve function and satisfaction with diabetic and depression care vs. UC. ..
- Healing Touch, Immunity, and Fatigue in Breast CancerSusan Lutgendorf; Fiscal Year: 2004....
- Biobehavioral-Cytokine Interactions in Ovarian CancerSusan Lutgendorf; Fiscal Year: 2007..Findings will have implications for innovative behavioral and pharmacological intervention strategies for ovarian cancer patients. ..
- Native Navigation across the Cancer Continuum in Comanche NationValerie S Eschiti; Fiscal Year: 2010....
- Multifaceted Oncology Depression Program for LatinosKathleen Ell; Fiscal Year: 2007..UC. Secondary questions include what is the effect of MODP on symptoms such as pain and fatigue and functional impairment from these symptoms. ..
- Healing Touch and Immunity in Advanced Cervical CancerSusan Lutgendorf; Fiscal Year: 2002....
- Oncology Depression Program--Latinas with CancerKathleen Ell; Fiscal Year: 2002....
- Tumor metastasis: Biobehavioral mechanismsAnil K Sood; Fiscal Year: 2009....
- MRI of Fetal Ventriculomegaly: Morphology and OutcomeDeborah Levine; Fiscal Year: 2007..unreadable] [unreadable]..
- ENHANCED EVALUATION OF FETAL CNS WITH ULTRAFAST MRIDeborah Levine; Fiscal Year: 2002..Thus the results of this study could significantly decrease morbidity of fetuses with ventriculomegaly. ..
- Genetic and Epigenetic Markers in Ovarian CancerElizabeth Swisher; Fiscal Year: 2006..These studies may identify new prognostic or diagnostic markers in ovarian cancer. Such markers could then be tested in prospective trials to determine their clinical utility. ..
- IMPROVING COMMUNICATION WITH IVF PATIENTS ABOUT RISKS SUCH AS MULTIPLE BIRTHSLINDA FRAZIER; Fiscal Year: 2008..The new materials will also help couples who achieve pregnancy to manage risks for increased maternal and neonatal problems among IVF singletons and multiples. [unreadable] [unreadable] [unreadable]..
- Improving Employment among Gynecologic Cancer SurvivorsLINDA FRAZIER; Fiscal Year: 2006..unreadable] [unreadable]..
- Fas/FasL System In Normal Mammary Gland DevelopmentGil Mor; Fiscal Year: 2003..With an improved foundation of the normal mammary physiology, we can advance the understanding of breast cancer, allowing the development of effective strategies for its treatment and prevention. ..
- A Molecular Signature of Early Cervical CarcinomaConcepcion Diaz Arrastia; Fiscal Year: 2007..I propose to identify a genomic and proteomic signature of cervical cancer that will predict the aggressive behavior of the tumor and function clinically to develop molecular-based treatment plans. ..
- Development of a Web Based Tobacco Cessation CurriculumJohn Spangler; Fiscal Year: 2007..The ultimate goal will be to develop a highly portable tobacco cessation curriculum that can be used a variety of educational settings. ..
- TOXICOLOGY OF ENVIRONMENT CONTAMINANTSStephen Safe; Fiscal Year: 2007..The proposed training program will continue to provide trainees with a challenging academic and research environment that will prepare them for future careers in academic, industry and government. ..
- Prostate Cancer ImmunotherapyRobert Darnell; Fiscal Year: 2007..Our results should indicate whether this new approach to DC based, immunotherapy has a potential role in the treatment of prostatic cancer as well as other malignancies. ..
- c-Myc, growth factor and breast cancerDezhong Liao; Fiscal Year: 2007..abstract_text> ..
- International Collaborative HNC ResearchElaine Smith; Fiscal Year: 2007..This aim is to determine whether there is an easily administered, sensitive biomarker that can predict HPV-HR status in HNC tumors prior to therapy.. [unreadable] [unreadable] [unreadable]..
- SUPPRESSION OF HUMAN GLIOBLASTOMA CELL GROWTH BY CX43Ruo Pan Huang; Fiscal Year: 2002..The elucidation of cx43 function involved in the tumor suppression with respect to activation of apoptosis eventually will provide a molecular basis for the development of anti-cancer compounds. ..
- Race/Ethnic Variability in survey Question Processing and ResponseTimothy Johnson; Fiscal Year: 2009..This is an important goal, as health surveys are one of the key yardsticks by which public health disparities are measured. ..
- Colon Cancer Inhibition by a Class of PPARgamma AgonistsStephen Safe; Fiscal Year: 2009..The proposed studies will provide mechanistic insights on PPARy-dependent inhibition of colon cancer and identify compounds for future clinical studies. ..
- Natural History of CIN2 in AdolescentsAnna Barbara Moscicki; Fiscal Year: 2007..S. and specifically assess how best to modify cytology-based screening, utilize HPV diagnostics, and tailor aoDrooriate follow-uo strategies for adolescents and vouna women diaanosed with CIN 2 ..
- Characterizing Mammalian Embryonic polyA Binding ProteinEmre Seli; Fiscal Year: 2008....
- Strategies Against HPV Related Genital Diseases in WomenBradley Monk; Fiscal Year: 2006..It is expected that Dr. Monk will have obtained extramural funding for both his laboratory and clinical studies by the end of the period of support requested. ..
- ALKYL PCDFS--INHIBITION OF MAMMARY CANCERStephen Safe; Fiscal Year: 2001..Thus the proposed studies will define a new mechanism-based class of antiestrogens that can be used alone or in combination with tamoxifen for treatment of breast and endometrial cancer. ..
- Promoting Breast Cancer Screening Via Computer V PhoneVictoria Champion; Fiscal Year: 2008..Stage of mammography adoption will be tested using logistic regression with ordinal outcome. Traditional cost and marginal cost-effectiveness analyses are planned. ..
- Transcripitonal and Genetic Profiles in HNSCCsElaine Smith; Fiscal Year: 2008..abstract_text> ..
- International Symposium on Cancer Metastasis and the Lymphovascular SystemSTANLEY LEONG; Fiscal Year: 2007..unreadable] [unreadable] [unreadable] [unreadable]..
- Effect of Continuous vs. Sequential Oral ContraceptionRICHARD LEGRO; Fiscal Year: 2004..Therefore, the risks and benefits of a CCOCP regimen are an important women's health issue that warrant investigation. ..
- Mechanisms of Growth Factor-Estrogen Receptor CrosstalkStephen Safe; Fiscal Year: 2006..abstract_text> ..
- Symposium on Cancer Metastasis and Lymphovascular SystemSTANLEY LEONG; Fiscal Year: 2004..abstract_text> ..
- Variations in plasma phytoestrogen levels in EuropePetra Peeters; Fiscal Year: 2004..This pilot study will determine whether the variation of phytoestrogen concentrations in the European EPIC population is sufficient to justify further large-scale prospective nested case-control studies. ..
- NATURAL HISTORY OF HPV--INFECTION TO NEOPLASIAAnna Barbara Moscicki; Fiscal Year: 2004..The understanding of both local and systemic immune responses to initial and subsequent HPV infections may be key in vaccine or therapeutic developments. ..
- ESTROGEN INDUCED RESPONSES VIA ER/SPL COMPLEXESStephen Safe; Fiscal Year: 2002..These results will ultimately facilitate design of chemotherapeutic approaches which target specific genes. ..
- GENETIC EPIDEMIOLOGY AND MECHANISMS IN ORAL CANCERElaine Smith; Fiscal Year: 2003..abstract_text> ..
- COMMUNITY INTERVENTION TO INCREASE MAMMOGRAPHY SCREENINGVictoria Champion; Fiscal Year: 2003..The primary outcomes at six month and 21 months will be tested by a chi-square statistic using logistic regression with two degrees of freedom. Cost effectiveness analysis is planned for the third aim. ..
- PHENOTYPIC AND PSYCHOSOCIAL STUDY OF THE L1307K MUTATIONHenry Lynch; Fiscal Year: 2004....
- EXERCISE INTERVENTION IN COLORECTAL POLYP PATIENTSAnne McTiernan; Fiscal Year: 2004..Results from this unique human experimental study will provide important information about mechanisms of exercise effects on colon carcinogenesis and about potential ..
- Meeting of American Society for Reproductive Immunology:Gil Mor; Fiscal Year: 2003..abstract_text> ..
- INSULIN RESISTANCE IN PCOS--SEQUELAE AND TREATMENTRICHARD LEGRO; Fiscal Year: 2005..Improving insulin action through diet and exercise, with and without weight loss, will result in lowered circulating insulin levels, lowered androgens and increased ovulatory frequency rate in PCOS women. ..
- Protein arrays to profile cytokine expression in ovaria*Ruo Pan Huang; Fiscal Year: 2005..The data will be analyzed using statistics and bioinformatics tool and correlated with pathological and clinical data. The successful outcome of this grant may impact on the development of new biomarkers for patient-care management. ..
- IMMUNE ACCEPTANCE OF PREGNANCYGil Mor; Fiscal Year: 2002..The significance of this proposal is not limited to reproductive problems. It is anticipated that these studies will lead to a better understanding of tumor behavior, actions of chemotherapeutic agents and transplant physiology. ..
- DOXYCYCLINE FOR BLEEDING IN PROGESTIN ONLY CONTRACEPTORSDavid Archer; Fiscal Year: 2006..If successful, DOX treatment could become an important adjuvant for treatment of this and possibly other inflammatory disorders effecting reproductive tract tissues. ..
- Molecular Basis of Young Onset Colorectal CancerLisa Boardman; Fiscal Year: 2006..Following achievement of these goals, I am confident that I will be ready to continue my career as a successful independent investigator committed to colerectal cancer prevention and control. ..
- CERVICAL CANCER--PREDICTIVE ASSAY BY MR IMAGINGNina Mayr; Fiscal Year: 2003....
- Coactivation of Estrogen Receptor alpha/Sp1Stephen Safe; Fiscal Year: 2006..abstract_text> ..
- 2,3,7,8,--TCDD Effects on the Estrogenic ResponsesStephen Safe; Fiscal Year: 2006..The proposed Aims will address important mechanistic considerations on IDRE-independent inhibitory AhR-ERa crosstalk and pathways critical for inhibition of mammary tumor growth by SAhRMs. ..
- Tolerance versus tumor immunity in PNDRobert Darnell; Fiscal Year: 2005..These experiments offer the possibility of developing new cancer treatments and advancing the understanding of autoimmune disease of the nervous system. ..
- PSYCHOLOGICAL INTERVENTION FOR WOMEN WITH BREAST CANCERBARBARA ANDERSEN; Fiscal Year: 2005....
- Sexual Functioning and QOL in Women with Cervical CancerDiane Bodurka; Fiscal Year: 2003..Our long-term goal is to evaluate the effectiveness of such interventions in randomized trials. Ultimately, we hope to integrate our findings into daily clinical practice. ..
- Structure/function studies of RBPs in neurologic diseaseRobert Darnell; Fiscal Year: 2005....
- Inhibition of Pancreatic Cancer by New PPARgamma Agonis*Stephen Safe; Fiscal Year: 2008..PPAR? -active C-substituted DIMs that inhibit pancreatic cancer cell growth in vitro and in vivo, and these will serve as lead compounds for development of new drugs for clinical treatment of this devastating disease ..
- EXERCISE, DIET, AND SEX HORMONES IN POSTMENOPAUSAL WOMENAnne McTiernan; Fiscal Year: 2008..Intervention adherence will be monitored via exercise and diet logs and weekly weighing. Potential adverse effects will be measured including injuries, overall bone density (DEXA), and Quality of Life. ..